Depressive states in the structure of postcovid syndrome: features and therapy
Open Access
- 30 March 2022
- journal article
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 56 (1), 16-24
- https://doi.org/10.31363/2313-7053-2022-56-1-16-24
Abstract
The article provides a review of the scientific literature devoted to postcoid conditions. The concept of postcovid syndrome, its structure, and epidemiology are disclosed. The article contains the results of 2 meetings of experts (psychiatrists, psychotherapists, neurologists) from different regions of Russia who had experience in providing care to persons with postkovid syndrome. Particular attention is paid to postcovid depression, its clinical characteristics, and the experience of therapy. It was noted that the severity of the post-coV syndrome did not depend on the severity of the infectious disease suffered. The leading variants of depressive syndromes observed in SARS-CoV-2 patients were: astheno-depressive, apato-depressive and anxious-depressive syndromes. Anhedonia, anxiety, cognitive disorders, insomnia, and hypochondria occupied a significant place in the structure of postcovid mental disorders. It is emphasized that persons with postcovid syndrome, as a rule, initially found themselves in the field of vision of internists, therefore, their training in the diagnosis of postcovid mental disorders is relevant. Clinical experience has demonstrated the feasibility of antidepressant therapy for postcovid depression and the high efficacy and safety, including the risk of drug interactions, of using vortioxetine, including prescribing the drug to the elderly and the somatically impaired. The article is illustrated with clinical examples.Keywords
This publication has 6 references indexed in Scilit:
- Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in KoreaBMC Infectious Diseases, 2022
- Patient symptoms and experience following COVID-19: results from a UK-wide surveyBMJ Open Respiratory Research, 2021
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysisScientific Reports, 2021
- Cognitive deficits in people who have recovered from COVID-19EClinicalMedicine, 2021
- Characterizing long COVID in an international cohort: 7 months of symptoms and their impactEClinicalMedicine, 2021
- A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive DisorderInternational Journal of Neuropsychopharmacology, 2017